Detalles de la búsqueda
1.
Anomalous kinetics of galactose-deficient IgA incurring nephropathy revealed by cross-scale optical imaging.
Kidney Int
; 103(2): 320-330, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36341730
2.
Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancer.
Mol Carcinog
; 62(7): 1001-1008, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37067398
3.
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastases.
BMC Med
; 20(1): 197, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644609
4.
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women.
Genomics
; 112(2): 1223-1232, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31306748
5.
Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.
BMC Cancer
; 20(1): 1209, 2020 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33297998
6.
Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.
Hum Mol Genet
; 26(2): 454-465, 2017 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28025329
7.
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening.
Cancer Immunol Immunother
; 67(3): 471-481, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29214427
8.
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.
BMC Cancer
; 18(1): 1171, 2018 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477470
9.
Distribution and prognosis of uncommon metastases from non-small cell lung cancer.
BMC Cancer
; 16: 149, 2016 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26911831
10.
Single nucleotide polymorphisms of MAGE-A3 gene and its clinical implications in Chinese patients with non-small cell lung cancer (NSCLC).
Chin J Cancer Res
; 27(3): 301-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26157327
11.
Lung cancer treatment disparities in China: a question in need of an answer.
Oncologist
; 19(10): 1084-90, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25223463
12.
Detecting the spectrum of multigene mutations in non-small cell lung cancer by Snapshot assay.
Chin J Cancer
; 33(7): 346-50, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24823994
13.
Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study.
Ther Adv Med Oncol
; 16: 17588359241229435, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38333112
14.
Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinoma.
Clin Transl Immunology
; 13(6): e1515, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38835955
15.
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.
Sci Bull (Beijing)
; 69(4): 535-543, 2024 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185589
16.
Redoxhigh phenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mutations diminishes tissue-resident memory CD8+ T cells and attenuates the efficacy of immunotherapy in lung adenocarcinoma.
Oncoimmunology
; 13(1): 2340154, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38601319
17.
Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical Outcomes.
J Thorac Oncol
; 19(4): 601-612, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981218
18.
BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.
Mol Cancer
; 12: 61, 2013 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23758992
19.
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
J Transl Med
; 11: 168, 2013 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23842453
20.
KRAS mutation in patients with lung cancer: a predictor for poor prognosis but not for EGFR-TKIs or chemotherapy.
Ann Surg Oncol
; 20(4): 1381-8, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23208128